rVSV vector vaccine (Emergent BioSolutions/Coalition for Epidemic Preparedness Innovations)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamerVSV vector vaccine (Emergent BioSolutions/Coalition for Epidemic Preparedness Innovations)
Drug Alias NamerVSV vector vaccine (Auro vaccines)rVSV vector vaccine (Profectus)EBS-LASV
ClassificationVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLassa Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGhana
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesCoalition for Epidemic Preparedness InnovationsEmergent Biosolutions Inc
Inactive CompaniesAuro Vaccines Llc +[2] 
Active IndicationsLassa Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A